Suzhou Building Science

Showing 2754 articles
Business

Gilead Sciences Oncology Update After Positive Trodelvy Keytruda Trial Results

Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...

Business

Carrier Global's AI Tool 'Tell Me More' Aims to Cement Its Building-Tech Leadership Amid Industry Labor Crunch

Carrier Global's Abound platform has rolled out a generative AI feature designed to provide facility managers with deeper operational insights and guided maintenance for over 150,000 connected assets. The move comes as the HVAC industry grapples with a worsening technician shortage, positioning the tool as a critical aid for knowledge retention and faster troubleshooting.